v3.26.1
Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)
$ in Millions
3 Months Ended
Mar. 31, 2026
USD ($)
segment
Mar. 31, 2025
USD ($)
Segment Reporting [Abstract]    
Number of reportable segments | segment 2  
Segment Reporting Information [Line Items]    
Number of reportable segments | segment 2  
Net sales $ 6,020 $ 5,866
Reclassification to: cost of sales 2,210 2,122
Research, development and engineering expenses 413 405
Selling, general and administrative expenses 2,281 2,300
Depreciation and amortization 397 361
Amortization of intangible assets (180) (167)
Segment operating income 936 837
Goodwill and other impairments 0 (35)
Net earnings 745 654
MedSurg and Neurotechnology:    
Segment Reporting Information [Line Items]    
Net sales 3,207 3,056
Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 6,020 5,866
Reclassification to: cost of sales 2,114 1,950
Research, development and engineering expenses 377 366
Selling, general and administrative expenses 1,810 1,784
Depreciation and amortization 174 155
Amortization of intangible assets (180) (167)
Segment operating income 1,546 1,611
Operating Segments | MedSurg and Neurotechnology:    
Segment Reporting Information [Line Items]    
Net sales 3,207 3,056
Reclassification to: cost of sales 1,291 1,175
Research, development and engineering expenses 231 208
Selling, general and administrative expenses 930 859
Depreciation and amortization 55 48
Segment operating income 700 757
Operating Segments | Orthopaedics    
Segment Reporting Information [Line Items]    
Net sales 2,813 2,810
Reclassification to: cost of sales 823 775
Research, development and engineering expenses 146 158
Selling, general and administrative expenses 880 925
Depreciation and amortization 119 107
Segment operating income 846 854
Segment Reporting, Reconciling Item, Corporate Nonsegment    
Segment Reporting Information [Line Items]    
Depreciation and amortization 43 39
Segment operating income (275) (267)
Segment Reconciling Items    
Segment Reporting Information [Line Items]    
Sale of inventory stepped up to fair value at acquisition 0 (34)
Acquisition and integration-related charges (19) (185)
Structural optimization and other special charges (118) (41)
Goodwill and other impairments 0 (35)
Medical device regulation (5) (12)
Recall-related matters (10) (33)
Regulatory and legal matters (3) 0
Net earnings $ 936 $ 837